The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancer
| Image |  |
|---|---|
| Description | scientific article published on 25 September 2020 |
| Author/s |
author: Chawnshang Chang |
| Publication date | September 25, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |